CAS No. |
20501-56-8 |
中文名称 |
(3S,6S,6aR,7R,7aR,8S,9S,10S,11aS,12S,12aR,14R)-1-乙基-6,10-二甲氧基-3-(甲氧基甲基)十四氢-11aH-3,6a,12-(epiethane[1,1,2]triyl)-7,9-甲桥萘并[2,3-b]azocine-8,11a-二醇 |
英文名称 |
(3S,6S,6aR,7R,7aR,8S,9S,10S,11aS,12S,12aR,14R)-1-Ethyl-6,10-dimethoxy-3-(methoxymethyl)tetradecahydro-11aH-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-8,11a-diol |
别名 |
20-Ethyl-1α,16β-dimethoxy-4-(methoxymethyl)aconitane-8,14α-diol;Talatizamine;TALATISAMINEA;Y0197;Aconitane-8,14-diol, 20-ethyl-1,16-dimethoxy-4-(methoxymethyl)-, (1α,14α,16β)-;alatisamine;(3S,6S,6aR,7R,7aR,8S,9S,10S,11aS,12S,12aR,14R)-1-Ethyl-6,10-dimethoxy-3-(methoxymethyl)tetradecahydro-11aH-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-8,11a-diol;KcsA,Inhibitor,Alzheimer's,Talatisamine,neurotoxicity,inhibit,Potassium Channel,disease |
标准英文名 |
(3S,6S,6aR,7R,7aR,8S,9S,10S,11aS,12S,12aR,14R)-1-ethyl-6,10-dimethoxy-3-(methoxymethyl)tetradecahydro-11aH-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-8,11a-diol |
分子式 |
C24H39NO5 |
分子量 |
421.58
|
精确分子量 |
421.28
|
SMILES |
CCN1C[C@]2(COC)CC[C@H](OC)[C@]34[C@@H]5C[C@H]6[C@H](O)[C@@H]5[C@](O)(C[C@@H]6OC)[C@@H](C[C@H]23)[C@@H]14 |
标准SMILES |
CCN1C[C@]2(COC)CC[C@H](OC)[C@@]34[C@H]1[C@H](C[C@H]23)[C@@]1(O)C[C@H](OC)[C@H]2C[C@@H]4[C@@H]1[C@H]2O |
用途 |
Talatisamine is a specific potassium (K⁺) channel blocker; it attenuates the neurotoxicity of beta-amyloid oligomers on cultured cortical neurons and shows potential in Alzheimer's disease research. |
InChIKey |
BDCURAWBZJMFIK-IBNAPJPSSA-N |